JP2019019114A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2019019114A5 JP2019019114A5 JP2017152771A JP2017152771A JP2019019114A5 JP 2019019114 A5 JP2019019114 A5 JP 2019019114A5 JP 2017152771 A JP2017152771 A JP 2017152771A JP 2017152771 A JP2017152771 A JP 2017152771A JP 2019019114 A5 JP2019019114 A5 JP 2019019114A5
- Authority
- JP
- Japan
- Prior art keywords
- water
- parabens
- soluble
- soluble polymer
- polyhydric alcohol
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims 69
- 239000000203 mixture Substances 0.000 claims 46
- 230000002335 preservative Effects 0.000 claims 42
- 239000003755 preservative agent Substances 0.000 claims 42
- 229920003169 water-soluble polymer Polymers 0.000 claims 34
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims 27
- QCDWFXQBSFUVSP-UHFFFAOYSA-N Phenoxyethanol Chemical compound OCCOC1=CC=CC=C1 QCDWFXQBSFUVSP-UHFFFAOYSA-N 0.000 claims 18
- 229960005323 Phenoxyethanol Drugs 0.000 claims 18
- 239000004615 ingredient Substances 0.000 claims 18
- 230000002421 anti-septic Effects 0.000 claims 17
- 229940087068 GLYCERYL CAPRYLATE Drugs 0.000 claims 14
- GHBFNMLVSPCDGN-UHFFFAOYSA-N Monoctanoin Chemical compound CCCCCCCC(=O)OCC(O)CO GHBFNMLVSPCDGN-UHFFFAOYSA-N 0.000 claims 14
- 108010039918 Polylysine Proteins 0.000 claims 14
- 229920000656 polylysine Polymers 0.000 claims 14
- NIXOWILDQLNWCW-UHFFFAOYSA-N acrylic acid Chemical compound OC(=O)C=C NIXOWILDQLNWCW-UHFFFAOYSA-N 0.000 claims 12
- 229920000642 polymer Polymers 0.000 claims 11
- 229920002678 cellulose Polymers 0.000 claims 10
- 239000001913 cellulose Substances 0.000 claims 10
- 239000000284 extract Substances 0.000 claims 10
- 210000003491 Skin Anatomy 0.000 claims 9
- 239000000178 monomer Substances 0.000 claims 8
- 230000001737 promoting Effects 0.000 claims 8
- DNIAPMSPPWPWGF-UHFFFAOYSA-N propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 claims 8
- 239000012530 fluid Substances 0.000 claims 7
- 125000005250 alkyl acrylate group Chemical group 0.000 claims 6
- 229920001888 polyacrylic acid Polymers 0.000 claims 6
- 239000000499 gel Substances 0.000 claims 5
- 239000002831 pharmacologic agent Substances 0.000 claims 5
- BJRNKVDFDLYUGJ-RMPHRYRLSA-N ARBUTIN Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1OC1=CC=C(O)C=C1 BJRNKVDFDLYUGJ-RMPHRYRLSA-N 0.000 claims 4
- POJWUDADGALRAB-PVQJCKRUSA-N Allantoin Natural products NC(=O)N[C@@H]1NC(=O)NC1=O POJWUDADGALRAB-PVQJCKRUSA-N 0.000 claims 4
- CGIGDMFJXJATDK-UHFFFAOYSA-N Indometacin Chemical group CC1=C(CC(O)=O)C2=CC(OC)=CC=C2N1C(=O)C1=CC=C(Cl)C=C1 CGIGDMFJXJATDK-UHFFFAOYSA-N 0.000 claims 4
- 240000007594 Oryza sativa Species 0.000 claims 4
- 235000007164 Oryza sativa Nutrition 0.000 claims 4
- 239000004599 antimicrobial Substances 0.000 claims 4
- PUPZLCDOIYMWBV-UHFFFAOYSA-N butylene glycol Chemical compound CC(O)CCO PUPZLCDOIYMWBV-UHFFFAOYSA-N 0.000 claims 4
- PEDCQBHIVMGVHV-UHFFFAOYSA-N glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 claims 4
- 235000011187 glycerol Nutrition 0.000 claims 4
- 125000002768 hydroxyalkyl group Chemical group 0.000 claims 4
- 239000007788 liquid Substances 0.000 claims 4
- 238000004519 manufacturing process Methods 0.000 claims 4
- 229910052751 metal Inorganic materials 0.000 claims 4
- 239000002184 metal Substances 0.000 claims 4
- CERQOIWHTDAKMF-UHFFFAOYSA-N methacrylic acid Chemical compound CC(=C)C(O)=O CERQOIWHTDAKMF-UHFFFAOYSA-N 0.000 claims 4
- 239000004584 polyacrylic acid Substances 0.000 claims 4
- 235000009566 rice Nutrition 0.000 claims 4
- 150000003839 salts Chemical class 0.000 claims 4
- 229910052708 sodium Inorganic materials 0.000 claims 4
- 239000011734 sodium Substances 0.000 claims 4
- 239000011780 sodium chloride Substances 0.000 claims 4
- NIXOWILDQLNWCW-UHFFFAOYSA-M acrylate Chemical compound [O-]C(=O)C=C NIXOWILDQLNWCW-UHFFFAOYSA-M 0.000 claims 3
- 239000003431 cross linking reagent Substances 0.000 claims 3
- 229920002126 Acrylic acid copolymer Polymers 0.000 claims 2
- 229920001817 Agar Polymers 0.000 claims 2
- 229960000458 Allantoin Drugs 0.000 claims 2
- 229960000271 Arbutin Drugs 0.000 claims 2
- 241000972773 Aulopiformes Species 0.000 claims 2
- 229940119217 Chamomile extract Drugs 0.000 claims 2
- SNPLKNRPJHDVJA-ZETCQYMHSA-N D-panthenol Chemical compound OCC(C)(C)[C@@H](O)C(=O)NCCCO SNPLKNRPJHDVJA-ZETCQYMHSA-N 0.000 claims 2
- 229960001193 Diclofenac Sodium Drugs 0.000 claims 2
- 229940101029 Dipotassium Glycyrrhizinate Drugs 0.000 claims 2
- QRZAKQDHEVVFRX-UHFFFAOYSA-N Felbinac Chemical compound C1=CC(CC(=O)O)=CC=C1C1=CC=CC=C1 QRZAKQDHEVVFRX-UHFFFAOYSA-N 0.000 claims 2
- SYTBZMRGLBWNTM-UHFFFAOYSA-N Flurbiprofen Chemical compound FC1=CC(C(C(O)=O)C)=CC=C1C1=CC=CC=C1 SYTBZMRGLBWNTM-UHFFFAOYSA-N 0.000 claims 2
- 108010010803 Gelatin Proteins 0.000 claims 2
- BIVBRWYINDPWKA-VLQRKCJKSA-L Glycyrrhizinate dipotassium Chemical compound [K+].[K+].O([C@@H]1[C@@H](O)[C@H](O)[C@H](O[C@@H]1O[C@H]1CC[C@]2(C)[C@H]3C(=O)C=C4[C@@H]5C[C@](C)(CC[C@@]5(CC[C@@]4(C)[C@]3(C)CC[C@H]2C1(C)C)C)C(O)=O)C([O-])=O)[C@@H]1O[C@H](C([O-])=O)[C@@H](O)[C@H](O)[C@H]1O BIVBRWYINDPWKA-VLQRKCJKSA-L 0.000 claims 2
- 241000208690 Hamamelis Species 0.000 claims 2
- 240000005979 Hordeum vulgare Species 0.000 claims 2
- 235000007340 Hordeum vulgare Nutrition 0.000 claims 2
- HEFNNWSXXWATRW-UHFFFAOYSA-N Ibuprofen Chemical compound CC(C)CC1=CC=C(C(C)C(O)=O)C=C1 HEFNNWSXXWATRW-UHFFFAOYSA-N 0.000 claims 2
- 229960000905 Indomethacin Drugs 0.000 claims 2
- DKYWVDODHFEZIM-UHFFFAOYSA-N Ketoprofen Chemical compound OC(=O)C(C)C1=CC=CC(C(=O)C=2C=CC=CC=2)=C1 DKYWVDODHFEZIM-UHFFFAOYSA-N 0.000 claims 2
- OZWKMVRBQXNZKK-UHFFFAOYSA-N Ketorolac Chemical compound OC(=O)C1CCN2C1=CC=C2C(=O)C1=CC=CC=C1 OZWKMVRBQXNZKK-UHFFFAOYSA-N 0.000 claims 2
- 229940083980 Lavender extract Drugs 0.000 claims 2
- HYYBABOKPJLUIN-UHFFFAOYSA-N Mefenamic acid Chemical compound CC1=CC=CC(NC=2C(=CC=CC=2)C(O)=O)=C1C HYYBABOKPJLUIN-UHFFFAOYSA-N 0.000 claims 2
- 210000001672 Ovary Anatomy 0.000 claims 2
- 229940101267 Panthenol Drugs 0.000 claims 2
- QYSPLQLAKJAUJT-UHFFFAOYSA-N Piroxicam Chemical compound OC=1C2=CC=CC=C2S(=O)(=O)N(C)C=1C(=O)NC1=CC=CC=N1 QYSPLQLAKJAUJT-UHFFFAOYSA-N 0.000 claims 2
- 210000002826 Placenta Anatomy 0.000 claims 2
- 240000000650 Plantago ovata Species 0.000 claims 2
- 235000003421 Plantago ovata Nutrition 0.000 claims 2
- 239000002202 Polyethylene glycol Substances 0.000 claims 2
- 229920001451 Polypropylene glycol Polymers 0.000 claims 2
- 239000004372 Polyvinyl alcohol Substances 0.000 claims 2
- 239000009223 Psyllium Substances 0.000 claims 2
- 229940070687 Psyllium Drugs 0.000 claims 2
- 241000235070 Saccharomyces Species 0.000 claims 2
- PRAKJMSDJKAYCZ-UHFFFAOYSA-N Squalane Chemical compound CC(C)CCCC(C)CCCC(C)CCCCC(C)CCCC(C)CCCC(C)C PRAKJMSDJKAYCZ-UHFFFAOYSA-N 0.000 claims 2
- 229920002472 Starch Polymers 0.000 claims 2
- MDKGKXOCJGEUJW-UHFFFAOYSA-N Suprofen Chemical compound C1=CC(C(C(O)=O)C)=CC=C1C(=O)C1=CC=CS1 MDKGKXOCJGEUJW-UHFFFAOYSA-N 0.000 claims 2
- 229960004492 Suprofen Drugs 0.000 claims 2
- 229940029983 VITAMINS Drugs 0.000 claims 2
- 229930003268 Vitamin C Natural products 0.000 claims 2
- 229930003427 Vitamin E Natural products 0.000 claims 2
- 229940046009 Vitamin E Drugs 0.000 claims 2
- 229940021016 Vitamin IV solution additives Drugs 0.000 claims 2
- NNJVILVZKWQKPM-UHFFFAOYSA-N Xylocaine Chemical compound CCN(CC)CC(=O)NC1=C(C)C=CC=C1C NNJVILVZKWQKPM-UHFFFAOYSA-N 0.000 claims 2
- 239000008272 agar Substances 0.000 claims 2
- -1 alkyl methacrylate Chemical compound 0.000 claims 2
- 229940069780 barley extract Drugs 0.000 claims 2
- 235000010633 broth Nutrition 0.000 claims 2
- 125000004181 carboxyalkyl group Chemical group 0.000 claims 2
- 235000020221 chamomile extract Nutrition 0.000 claims 2
- 229920001436 collagen Polymers 0.000 claims 2
- 150000001875 compounds Chemical class 0.000 claims 2
- 229920001577 copolymer Polymers 0.000 claims 2
- 239000006071 cream Substances 0.000 claims 2
- 238000004132 cross linking Methods 0.000 claims 2
- 229960001259 diclofenac Drugs 0.000 claims 2
- DCOPUUMXTXDBNB-UHFFFAOYSA-N diclofenac Chemical compound OC(=O)CC1=CC=CC=C1NC1=C(Cl)C=CC=C1Cl DCOPUUMXTXDBNB-UHFFFAOYSA-N 0.000 claims 2
- KPHWPUGNDIVLNH-UHFFFAOYSA-M diclofenac sodium Chemical compound [Na+].[O-]C(=O)CC1=CC=CC=C1NC1=C(Cl)C=CC=C1Cl KPHWPUGNDIVLNH-UHFFFAOYSA-M 0.000 claims 2
- 230000000694 effects Effects 0.000 claims 2
- 239000000839 emulsion Substances 0.000 claims 2
- 230000001747 exhibiting Effects 0.000 claims 2
- 229960000192 felbinac Drugs 0.000 claims 2
- 238000000855 fermentation Methods 0.000 claims 2
- 230000004151 fermentation Effects 0.000 claims 2
- 229960002390 flurbiprofen Drugs 0.000 claims 2
- 239000008273 gelatin Substances 0.000 claims 2
- 229920000159 gelatin Polymers 0.000 claims 2
- 235000019322 gelatine Nutrition 0.000 claims 2
- 235000011852 gelatine desserts Nutrition 0.000 claims 2
- 229920002674 hyaluronan Polymers 0.000 claims 2
- 229960003160 hyaluronic acid Drugs 0.000 claims 2
- 229960001680 ibuprofen Drugs 0.000 claims 2
- 229950005954 ibuprofen piconol Drugs 0.000 claims 2
- 229960000991 ketoprofen Drugs 0.000 claims 2
- 229960004752 ketorolac Drugs 0.000 claims 2
- 235000020723 lavender extract Nutrition 0.000 claims 2
- 229960004194 lidocaine Drugs 0.000 claims 2
- 229960002373 loxoprofen Drugs 0.000 claims 2
- BAZQYVYVKYOAGO-UHFFFAOYSA-M loxoprofen sodium hydrate Chemical compound O.O.[Na+].C1=CC(C(C([O-])=O)C)=CC=C1CC1C(=O)CCC1 BAZQYVYVKYOAGO-UHFFFAOYSA-M 0.000 claims 2
- 229960003464 mefenamic acid Drugs 0.000 claims 2
- 238000000034 method Methods 0.000 claims 2
- 235000020957 pantothenol Nutrition 0.000 claims 2
- 239000011619 pantothenol Substances 0.000 claims 2
- 229960002702 piroxicam Drugs 0.000 claims 2
- 229920001223 polyethylene glycol Polymers 0.000 claims 2
- 230000000379 polymerizing Effects 0.000 claims 2
- 150000008442 polyphenolic compounds Chemical class 0.000 claims 2
- 235000013824 polyphenols Nutrition 0.000 claims 2
- 229920002451 polyvinyl alcohol Polymers 0.000 claims 2
- 229920000036 polyvinylpyrrolidone Polymers 0.000 claims 2
- 239000001267 polyvinylpyrrolidone Substances 0.000 claims 2
- 235000013855 polyvinylpyrrolidone Nutrition 0.000 claims 2
- ACEWLPOYLGNNHV-UHFFFAOYSA-N pyridin-2-ylmethyl 2-[4-(2-methylpropyl)phenyl]propanoate Chemical compound C1=CC(CC(C)C)=CC=C1C(C)C(=O)OCC1=CC=CC=N1 ACEWLPOYLGNNHV-UHFFFAOYSA-N 0.000 claims 2
- 235000019515 salmon Nutrition 0.000 claims 2
- KEAYESYHFKHZAL-UHFFFAOYSA-N sodium Chemical compound [Na] KEAYESYHFKHZAL-UHFFFAOYSA-N 0.000 claims 2
- MAKUBRYLFHZREJ-JWBQXVCJSA-M sodium;(2S,3S,4R,5R,6R)-3-[(2S,3R,5S,6R)-3-acetamido-5-hydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-4,5,6-trihydroxyoxane-2-carboxylate Chemical compound [Na+].CC(=O)N[C@@H]1C[C@H](O)[C@@H](CO)O[C@H]1O[C@@H]1[C@@H](C([O-])=O)O[C@@H](O)[C@H](O)[C@H]1O MAKUBRYLFHZREJ-JWBQXVCJSA-M 0.000 claims 2
- 239000007921 spray Substances 0.000 claims 2
- 229940032094 squalane Drugs 0.000 claims 2
- 239000008107 starch Substances 0.000 claims 2
- 235000019698 starch Nutrition 0.000 claims 2
- 239000011732 tocopherol Substances 0.000 claims 2
- 125000002640 tocopherol group Chemical group 0.000 claims 2
- 229930003799 tocopherols Natural products 0.000 claims 2
- 235000019149 tocopherols Nutrition 0.000 claims 2
- 235000013343 vitamin Nutrition 0.000 claims 2
- 239000011782 vitamin Substances 0.000 claims 2
- 235000019154 vitamin C Nutrition 0.000 claims 2
- 239000011718 vitamin C Substances 0.000 claims 2
- 150000003700 vitamin C derivatives Chemical class 0.000 claims 2
- 235000019165 vitamin E Nutrition 0.000 claims 2
- 239000011709 vitamin E Substances 0.000 claims 2
- 150000003712 vitamin E derivatives Chemical class 0.000 claims 2
- 229930003231 vitamins Natural products 0.000 claims 2
- 241000283690 Bos taurus Species 0.000 claims 1
- LXCFILQKKLGQFO-UHFFFAOYSA-N Methylparaben Chemical compound COC(=O)C1=CC=C(O)C=C1 LXCFILQKKLGQFO-UHFFFAOYSA-N 0.000 claims 1
- 239000000853 adhesive Substances 0.000 claims 1
- 230000001070 adhesive Effects 0.000 claims 1
- 125000000217 alkyl group Chemical group 0.000 claims 1
- 235000019658 bitter taste Nutrition 0.000 claims 1
- 239000002537 cosmetic Substances 0.000 claims 1
- 239000003814 drug Substances 0.000 claims 1
- 229940079593 drugs Drugs 0.000 claims 1
- 229920000058 polyacrylate Polymers 0.000 claims 1
- YGSDEFSMJLZEOE-UHFFFAOYSA-M salicylate Chemical compound OC1=CC=CC=C1C([O-])=O YGSDEFSMJLZEOE-UHFFFAOYSA-M 0.000 claims 1
- 229960001860 salicylate Drugs 0.000 claims 1
- 150000003873 salicylate salts Chemical class 0.000 claims 1
- 239000000126 substance Substances 0.000 claims 1
- 230000001629 suppression Effects 0.000 claims 1
- 239000000341 volatile oil Substances 0.000 claims 1
- 238000010792 warming Methods 0.000 claims 1
Claims (27)
- ïŒïŒ¡ïŒæ°ŽãšãïŒïŒ¢ïŒåèšæ°Žã«æº¶è§£å¯èœãªæ©èœæ§æåãšããå«æããå«æ°Žçµæç©ã§ãã£ãŠã
å°ãªããšãã
ïŒïŒ£ïŒåèšæ°Žã«æº¶è§£å¯èœåã¯çžæº¶å¯èœãªé²è æ§ä¿é²äœçšãå¥ããå€äŸ¡ã¢ã«ã³ãŒã«ãšã
ïŒïŒ¥ïŒåèšæ°Žåã³ïŒåã¯å€äŸ¡ã¢ã«ã³ãŒã«ã«æº¶è§£å¯èœãªãã©ãã³é¡ä»¥å€ã®é²è å€ãšã
ãå«æãã
åèšãã©ãã³é¡ä»¥å€ã®é²è å€ãããã§ããã·ãšã¿ããŒã«ãšãã«ããªã«é žã°ãªã»ãªã«ãšãããªãªã·ã³ãšããããªã矀ããéžã°ããå°ãªããšãäžã€ã®ãã©ãã³é¡ä»¥å€ã®é²è å€ã
ãå«æããŠãªãã
é²è æ§ãæããããšãç¹åŸŽãšããå«æ°Žçµæç©ã - é²è æ§ä¿é²äœçšãå¥ããåèšå€äŸ¡ã¢ã«ã³ãŒã«ã¯ãå°ãªããšãããããã¬ã³ã°ãªã³ãŒã«ãããã¬ã³ã°ãªã³ãŒã«åã³ã°ãªã»ãªã³ãããªã矀ããéžã°ããå°ãªããšãäžã€ã®å€äŸ¡ã¢ã«ã³ãŒã«ãå«æãããããšãç¹åŸŽãšããè«æ±é ïŒã«èšèŒã®å«æ°Žçµæç©ã
- é²è æ§ä¿é²äœçšãå¥ããåèšå€äŸ¡ã¢ã«ã³ãŒã«ã¯ãå°ãªããšããå šéã«å¯ŸããŠã
ïŒééïŒ ä»¥äžã®ãããã¬ã³ã°ãªã³ãŒã«ã
ïŒééïŒ ä»¥äžã®ããã¬ã³ã°ãªã³ãŒã«ãåã³ã
ïŒééïŒ ä»¥äžã®ã°ãªã»ãªã³ã
ãããªã矀ããéžã°ããå°ãªããšãäžã€ã®å€äŸ¡ã¢ã«ã³ãŒã«ãå«æããã
ããšãç¹åŸŽãšããè«æ±é ïŒãŸãã¯ïŒã«èšèŒã®å«æ°Žçµæç©ã - åèšãã©ãã³é¡ä»¥å€ã®é²è å€ã¯ãå°ãªããšããå šéã«å¯ŸããŠã
ïŒïŒïŒãïŒïŒïŒééïŒ ã®ãã§ããã·ãšã¿ããŒã«ã
ïŒïŒïŒïŒãïŒïŒïŒééïŒ ã®ã«ããªã«é žã°ãªã»ãªã«ãåã³ã
ïŒïŒïŒïŒãïŒïŒïŒééïŒ ã®ããªãªã·ã³ã
ãããªã矀ããéžã°ããå°ãªããšãäžã€ã®ãã©ãã³é¡ä»¥å€ã®é²è å€ããå«æããŠãªãã
è«æ±é ïŒä¹è³ïŒã®ããããã«èšèŒã®å«æ°Žçµæç©ã - åèšãã©ãã³é¡ä»¥å€ã®é²è å€ã¯ãå°ãªããšãã
ãã§ããã·ãšã¿ããŒã«ãšã
ã«ããªã«é žã°ãªã»ãªã«åã³ïŒåã¯ããªãªã·ã³ãšã
ã®åæ¹ã®é²è å€ãå«æããŠãªãããšãç¹åŸŽãšããè«æ±é ïŒä¹è³ïŒã®ããããã«èšèŒã®å«æ°Žçµæç©ã - åèšãã©ãã³é¡ä»¥å€ã®é²è å€ã¯ãå°ãªããšãã
ãã§ããã·ãšã¿ããŒã«ãšã
ã«ããªã«é žã°ãªã»ãªã«ãšã
ã®åæ¹ã®é²è å€ãå«æãã
åèšãã©ãã³é¡ä»¥å€ã®é²è å€ã®æå°ã®å«æéããå šéã«å¯ŸããŠã
ãã§ããã·ãšã¿ããŒã«å«æéã軞ãšããã«ããªã«é žã°ãªã»ãªã«å«æéã軞ãšãã座æšã«ãããŠã軞ã«ããããã§ããã·ãšã¿ããŒã«å«æéãïŒïŒïŒïŒééïŒ ã§ããç¹ãšïŒ¹è»žã«ãããã«ããªã«é žã°ãªã»ãªã«å«æéãïŒïŒïŒïŒïŒééïŒ ã§ããç¹ãšãçµã¶çŽç·ãããäžåŽé åã«ããããã«ããã§ããã·ãšã¿ããŒã«ãšã«ããªã«é žã°ãªã»ãªã«ãšã®åæ¹ã®é²è å€ãå«æãããŠãªãã
ããšãç¹åŸŽãšããè«æ±é ïŒã«èšèŒã®å«æ°Žçµæç©ã - åèšãã©ãã³é¡ä»¥å€ã®é²è å€ã¯ãå°ãªããšãã
ãã§ããã·ãšã¿ããŒã«ãšã
ããªãªã·ã³ãšã
ã®åæ¹ã®é²è å€ãå«æãã
åèšãã©ãã³é¡ä»¥å€ã®é²è å€ã®æå°ã®å«æéããå šéã«å¯ŸããŠã
ãã§ããã·ãšã¿ããŒã«å«æéã軞ãšããããªãªã·ã³å«æéã軞ãšãã座æšã«ãããŠã軞ã«ããããã§ããã·ãšã¿ããŒã«å«æéãïŒïŒïŒïŒééïŒ ã§ããç¹ãšïŒ¹è»žã«ãããããªãªã·ã³å«æéãïŒïŒïŒïŒïŒééïŒ ã§ããç¹ãšãçµã¶çŽç·ãããäžåŽé åã«ããããã«ããã§ããã·ãšã¿ããŒã«ãšããªãªã·ã³ãšã®åæ¹ã®é²è å€ãå«æãããŠãªãã
ããšãç¹åŸŽãšããè«æ±é ïŒã«èšèŒã®å«æ°Žçµæç©ã - ãã©ãã³é¡ã®é²è å€ãå«æããªãã
ããšãç¹åŸŽãšããè«æ±é ïŒä¹è³ïŒã®ããããã«èšèŒã®å«æ°Žçµæç©ã - åèšãã©ãã³é¡ä»¥å€ã®é²è å€ã«å ããŠã
ããã«ãïŒïŒŠïŒå šéã«å¯ŸããŠïŒïŒïŒïŒééïŒ ä»¥äžã®ãã©ãã³é¡ãå«æããã
ããšãç¹åŸŽãšããè«æ±é ïŒä¹è³ïŒã®ããããã«èšèŒã®å«æ°Žçµæç©ã - åèšæ©èœæ§æåã¯ãæ°Žã«æº¶è§£å¯èœãªæ°Žæº¶æ§é«ååãå«æãã
åèšæ°Žæº¶æ§é«åã¯åèšæ°Žã«æº¶è§£ããããšãšãã«ã
åèšæ°Žãåèšæ°Žæº¶æ§é«ååãåèšå€äŸ¡ã¢ã«ã³ãŒã«ãåã³ãåèšãã©ãã³é¡ä»¥å€ã®é²è å€ã¯ãäºãã«æº¶è§£åã¯çžæº¶ããç¶æ ã§ããã
ããšãç¹åŸŽãšããè«æ±é ïŒä¹è³ïŒã®ããããã«èšèŒã®å«æ°Žçµæç©ã - åèšæ°Žæº¶æ§é«ååã¯ã
ïŒïœïŒååæ§é çã«ç¶²ç®æ§é ã«æ¶æ©å¯èœãªæ¶æ©æ§æ°Žæº¶æ§é«ååãå«æãã
çŽïŒïŒãçŽïŒïŒâã®åžžæž©ä»è¿ã«ãããŠãåèšæ¶æ©æ§æ°Žæº¶æ§é«ååã¯ãæ¶æ©å€ãååš ããç¶æ ã«ãããŠãåèšæ°Žã«æº¶è§£ãããç¶æ ã§æ¶æ©ãããæµåæ§ã®ãªãã²ã«ç¶ãæ ããã
ïŒïœïŒååæ§é çã«ç¶²ç®æ§é ã«æ¶æ©å¯èœãªæ¶æ©æ§æ°Žæº¶æ§é«ååãå«æãã
çŽïŒïŒãçŽïŒïŒâã®åžžæž©ä»è¿ã«ãããŠãåèšæ¶æ©æ§æ°Žæº¶æ§é«ååã¯ãæ¶æ©å€ãååš ããªãç¶æ ã«ãããŠãæ°Žã«æº¶è§£ãããç¶æ ã§æ¶æ©ãããªãæµåæ§ã®ããç²çš ç¶ãæ ããã
ïŒïœïŒååæ§é çã«æ¶æ©ããªãéæ¶æ©æ§æ°Žæº¶æ§é«ååãå«æãã
çŽïŒïŒãçŽïŒïŒâã®åžžæž©ä»è¿ã«ãããŠãåèšéæ¶æ©æ§æ°Žæº¶æ§é«ååã¯ãæ°Žã«æº¶è§£ã ããç¶æ ã§æ¶æ©ãããªãæµåæ§ã®ããç²çš ç¶ãæããã
åã¯ã
ïŒïœïŒååæ§é çã«ç¶²ç®æ§é ã«æ¶æ©å¯èœãªæ¶æ©æ§æ°Žæº¶æ§é«ååãšååæ§é çã«æ¶æ©ããªã éæ¶æ©æ§æ°Žæº¶æ§é«ååãšã®åæ¹ã®æ°Žæº¶æ§é«ååãæãã
çŽïŒïŒãçŽïŒïŒâã®åžžæž©ä»è¿ã«ãããŠãåèšæ¶æ©æ§æ°Žæº¶æ§é«ååã¯ãæ¶æ©å€ãååš ããç¶æ ã«ãããŠãåèšæ°Žã«æº¶è§£ãããç¶æ ã§æ¶æ©ãããæµåæ§ã®ãªãã²ã«ç¶ãæ ããåèšéæ¶æ©æ§æ°Žæº¶æ§é«ååã¯ãæ°Žã«æº¶è§£ãããç¶æ ã§æ¶æ©ãããªãæµåæ§ã®ã ãç²çš ç¶ãæããã
ããšãç¹åŸŽãšããè«æ±é ïŒïŒã«èšèŒã®å«æ°Žçµæç©ã - åèšæ©èœæ§æåãšããŠã®åèšæ°Žæº¶æ§é«ååã¯ãæ¶æ©æ§æ°Žæº¶æ§é«åååã³éæ¶æ©æ§æ°Žæº¶æ§é«ååã®ãã¡ã®å°ãªããšãäžã€ãå«æãã
åèšæ°Žæº¶æ§é«ååã¯åèšæ°Žã«æº¶è§£ããç¶æ ã§å«æãããŠãªãã
åèšæ¶æ©æ§æ°Žæº¶æ§é«ååã¯ã
ïŒïœïŒã¢ã¯ãªã«é žãã¡ã¿ã¯ãªã«é žãåã³ããããã®äžäŸ¡ã®éå±å¡©ã®ãã¡ã®å°ãªããšãäžã€ ã®ã¢ã¯ãªã«é žç³»åéäœãéåããŠåŸãããæ¶æ©åã¢ã¯ãªã«é žç³»ããªãã
ïŒïœïœïŒïŒïœïŒã¢ã¯ãªã«é žãã¡ã¿ã¯ãªã«é žãåã³ããããã®äžäŸ¡ã®éå±å¡©ã®ãã¡ã®å°ãªã ãšãäžã€ã®ã¢ã¯ãªã«é žç³»åéäœãšãïŒïœïŒã¢ã¯ãªã«é žã¢ã«ãã«åã³ã¡ã¿ã¯ãªã«é žã¢ ã«ãã«ã®ãã¡ã®å°ãªããšãäžã€ã®ã¢ã¯ãªã«é žã¢ã«ãã«ç³»åéäœãšããå ±éåããŠåŸ ãããæ¶æ©åã¢ã¯ãªã«é žç³»å ±éåããªãã
ïŒïœïœïœïŒããªã¢ã¯ãªã«é žãéšåçã«äžåããéšåäžååããªã¢ã¯ãªã«é žã®æ¶æ©åã¢ã¯ãª ã«é žç³»ããªãã
ïŒïœïœïŒæ¶æ©åã«ã«ããã·ããã«ããªãã
åã³ïŒåã¯ã
ïŒïœïŒã«ã«ããã·ã¢ã«ãã«ã»ã«ããŒã¹ãããªãŠã ãåã³ïŒåã¯ãããããã·ã¢ã«ãã«ã»ã« ããŒã¹ãããªãŠã ã®æ¶æ©åã»ã«ããŒã¹ååç©ã§ããã
åèšéæ¶æ©æ§æ°Žæº¶æ§é«ååã¯ã
ïŒïœïœïŒããªããã«ã¢ã«ã³ãŒã«ãããªãšãã¬ã³ã°ãªã³ãŒã«ãããªãããã¬ã³ã°ãªã³ãŒã«ã ã¢ã¯ãªã«é žãã³ãã³ãããªã¢ã¯ãªã«é žã¢ã«ãã«ãã«ã«ããã·ã¢ã«ãã«ã»ã«ããŒã¹ã ããããã·ã¢ã«ãã«ã»ã«ããŒã¹ãããªããã«ãããªãã³ãã¢ã¯ãªã«é žã¢ã«ãã«ãšå¯ ã¢ãããšã®å ±éåããªãããŒã©ãã³ãåã³ãå¯å€©ããããªã矀ããéžã°ããå°ãªã ãšãäžã€ã®éæ¶æ©æ§æ°Žæº¶æ§é«ååã§ããã
ããšãç¹åŸŽãšããè«æ±é ïŒïŒã«èšèŒã®å«æ°Žçµæç©ã - åèšå€äŸ¡ã¢ã«ã³ãŒã«ã¯ãå šéã«å¯ŸããŠãïŒééïŒ ä»¥äžãå«æãã
åèšãã©ãã³é¡ä»¥å€ã®é²è å€ã¯ãå šéã«å¯ŸããŠã
ïŒïŒïŒãïŒïŒïŒééïŒ ã®ãã§ããã·ãšã¿ããŒã«ã
ïŒïŒïŒïŒãïŒïŒïŒééïŒ ã®ã«ããªã«é žã°ãªã»ãªã«ãåã³ã
ïŒïŒïŒïŒãïŒïŒïŒééïŒ ã®ããªãªã·ã³ã
ãããªã矀ããéžã°ããå°ãªããšãäžã€ã®ãã©ãã³é¡ä»¥å€ã®é²è å€ãå«æãã
åèšæ°Žæº¶æ§é«ååã¯ãå šéã«å¯ŸããŠãïŒééïŒ ä»¥äžãå«æããŠãªãã
ããšãç¹åŸŽãšããè«æ±é ïŒïŒä¹è³ïŒïŒã®ããããã«èšèŒã®å«æ°Žçµæç©ã - åèšæ©èœæ§æåã¯å¹èœä»äžæ©èœæ§æåãå«æãã
åèšå¹èœä»äžæ©èœæ§æåã¯ãè¬ç掻æ§æåãèæ¹åæåãåã³ãè³éŠæåããããªã矀ããéžã°ããå°ãªããšãäžã€ã§ãããããšãç¹åŸŽãšããè«æ±é ïŒä¹è³ïŒã®ããããã«èšèŒã®å«æ°Žçµæç©ã - åèšæ©èœæ§æåã¯ã氎溶æ§é«ååãšå¹èœä»äžæ©èœæ§æåãšãå«æãã
åèšå¹èœä»äžæ©èœæ§æåã¯ãè¬ç掻æ§æåãèæ¹åæåãåã³ãè³éŠæåããããªã矀ããéžã°ããå°ãªããšãäžã€ã§ããã
ããšãç¹åŸŽãšããè«æ±é ïŒä¹è³ïŒïŒã®ããããã«èšèŒã®å«æ°Žçµæç©ã - åèšè¬ç掻æ§æåã¯ãã€ã³ãã¡ã¿ã·ã³ããããœãããã§ã³ãã±ããããã§ã³ããžã¯ããã§ããã¯ããžã¯ããã§ããã¯ãããªãŠã ããã§ã«ããã¯ããããã·ã«ã ãã¹ãããã§ã³ã ã€ããããã§ã³ãã€ããããã§ã³ãã³ããŒã«ãã±ããã©ã¯ããªãã«ã€ã³ããã«ã«ããããã§ã³ãã¡ãã§ãã é žãã°ãªãã«ãªãã³é žãžã«ãªãŠã ãåã³ããµã«ãã«é žãšã¹ãã«é¡ãããªã矀ããéžã°ããå°ãªããšãäžã€ã§ããã
åèšèæ¹åæåã¯ããã³ãã§ããŒã«é¡ããã©ã»ã³ã¿ãšãã¹é¡ããã¢ã«ãã³é žé¡ããšã³ã³ã¶ã€ã ãã¢ã«ããã³ãã³ã©ãŒã²ã³é¡ãããªãã§ããŒã«é¡ãã¢ã©ã³ãã€ã³ãã¹ã¯ã¯ã©ã³ããã³ãããŒã«ãã«ããã¬ãšãã¹ãããã¡ãªã¹ãšãã¹ãã©ãã³ããŒãšãã¹ãããã ã®ãšãã¹ããªãªãã¯ãšãã¹ãç±³ãšãã¹é¡ããµã±åµå·£ãšãã¹é¡ããµãã«ããã»ã¹ãç±³çºé µæ¶²ããã¿ãã³ïŒ£é¡ããã¿ãã³ïŒ¥é¡ãåã³ããã¿ãã³é¡ãããªã矀ããéžã°ããå°ãªããšãäžã€ã§ããã
åèšè³éŠæåã¯è³éŠãçºçãã粟油æåã§ããã
ããšãç¹åŸŽãšããè«æ±é ïŒïŒãŸãã¯ïŒïŒã«èšèŒã®å«æ°Žçµæç©ã - ããã«ãè¿œå æåãå«æãã
åèšè¿œå æåã¯ã
ïŒïŒ«âïŒïŒå£ã«å«ãã å Žåã«èŠã¿ãæããŠèª€é£ãæå¶ããæ©èœãæãã誀é£é²æ¢æåã
ïŒïŒ«âïŒïŒæž 涌æãå¥ããæž æ¶Œæä»äžæåã
ïŒïŒ«âïŒïŒæž©æãå¥ããæž©ææž©æä»äžæåãåã³ã
ïŒïŒ«âïŒïŒïœïŒšã調æŽããïœïŒšèª¿æŽæåã
ãããªã矀ããéžã°ããå°ãªããšãäžã€ã®è¿œå æåãå«æãããããšãç¹åŸŽãšããè«æ±é ïŒä¹è³ïŒïŒã®ããããã«èšèŒã®å«æ°Žçµæç©ã - ïŒïŒ¡ïŒæ°ŽãšãïŒïŒ¢ïŒåèšæ°Žã«æº¶è§£å¯èœãªæ©èœæ§æåãšããå«æããå«æ°Žçµæç©ã§ãã£ãŠãå°ãªããšãã
ïŒïŒ£ïŒåèšæ°Žã«æº¶è§£å¯èœåã¯çžæº¶å¯èœãªé²è æ§ä¿é²äœçšãå¥ããå€äŸ¡ã¢ã«ã³ãŒã«ãšã
ïŒïŒ¥ïŒåèšæ°Žåã³ïŒåã¯å€äŸ¡ã¢ã«ã³ãŒã«ã«æº¶è§£å¯èœãªãã©ãã³é¡ä»¥å€ã®é²è å€ãšã
ãå«æãã
åèšãã©ãã³é¡ä»¥å€ã®é²è å€ãããã§ããã·ãšã¿ããŒã«ãšãã«ããªã«é žã°ãªã»ãªã«ãšãããªãªã·ã³ãšããããªã矀ããéžã°ããå°ãªããšãäžã€ã®ãã©ãã³é¡ä»¥å€ã®é²è å€ã
ãå«æããŠãªãã
液ç¶ãã¹ãã¬ãŒç¶ãã¯ãªãŒã ç¶ãä¹³åç¶ãåã¯ãã²ã«ç¶ã®åœ¢æ ãæãã
人äœç®èã«å¡åžãä»çãåã¯ã貌ä»ããŠé©çšå¯èœã§ããããšãç¹åŸŽãšããã
è«æ±é ïŒä¹è³ïŒïŒã®ããããã«èšèŒã®å«æ°Žçµæç©ã - ïŒïŒ¡ïŒæ°ŽãšãïŒïŒ¢ïŒåèšæ°Žã«æº¶è§£å¯èœãªæ©èœæ§æåãšããå«æããå«æ°Žçµæç©ã§ãã£ãŠãå°ãªããšãã
ïŒïŒ£ïŒåèšæ°Žã«æº¶è§£å¯èœåã¯çžæº¶å¯èœãªé²è æ§ä¿é²äœçšãå¥ããå€äŸ¡ã¢ã«ã³ãŒã«ãšã
ïŒïŒ¥ïŒåèšæ°Žåã³ïŒåã¯å€äŸ¡ã¢ã«ã³ãŒã«ã«æº¶è§£å¯èœãªãã©ãã³é¡ä»¥å€ã®é²è å€ãšã
ãå«æãã
åèšãã©ãã³é¡ä»¥å€ã®é²è å€ã¯ã
ãã§ããã·ãšã¿ããŒã«ãšã
ã«ããªã«é žã°ãªã»ãªã«åã³ïŒåã¯ããªãªã·ã³ãšã
åæ¹ã®é²è å€ãå«æããŠãªã
液ç¶ãã¹ãã¬ãŒç¶ãã¯ãªãŒã ç¶ãä¹³åç¶ãåã¯ãã²ã«ç¶ã®åœ¢æ ãæãã
人äœç®èã«å¡åžãä»çãåã¯ã貌ä»ããŠé©çšå¯èœã§ããããšãç¹åŸŽãšããã
è«æ±é ïŒã«èšèŒã®å«æ°Žçµæç©ã - ïŒïŒ¡ïŒæ°ŽãšãïŒïŒ¢ïŒåèšæ°Žã«æº¶è§£å¯èœãªæ©èœæ§æåãšããå«æããå«æ°Žçµæç©ã§ãã£ãŠãå°ãªããšãã
ïŒïŒ£ïŒåèšæ°Žã«æº¶è§£å¯èœåã¯çžæº¶å¯èœãªé²è æ§ä¿é²äœçšãå¥ããå€äŸ¡ã¢ã«ã³ãŒã«ãšã
ïŒïŒ¥ïŒåèšæ°Žåã³ïŒåã¯å€äŸ¡ã¢ã«ã³ãŒã«ã«æº¶è§£å¯èœãªãã©ãã³é¡ä»¥å€ã®é²è å€ãšã
ãå«æãã
åèšãã©ãã³é¡ä»¥å€ã®é²è å€ãããã§ããã·ãšã¿ããŒã«ãšãã«ããªã«é žã°ãªã»ãªã«ãšãããªãªã·ã³ãšããããªã矀ããéžã°ããå°ãªããšãäžã€ã®ãã©ãã³é¡ä»¥å€ã®é²è å€ã
ãå«æããŠãªãã
é²è æ§ä¿é²äœçšãå¥ããåèšå€äŸ¡ã¢ã«ã³ãŒã«ã¯ããããã¬ã³ã°ãªã³ãŒã«ãããã¬ã³ã°ãªã³ãŒã«ãåã³ãã°ãªã»ãªã³ããããªã矀ããéžã°ããå°ãªããšãäžã€ã®å€äŸ¡ã¢ã«ã³ãŒã«ãå«æãã
åèšæ©èœæ§æåã¯å¹èœä»äžæ©èœæ§æåãå«æããåèšå¹èœä»äžæ©èœæ§æåã¯ãè¬ç掻æ§æåãåã³ïŒåã¯ãèæ¹åæåãå«æãã
åèšè¬ç掻æ§æåã¯ãã€ã³ãã¡ã¿ã·ã³ããããœãããã§ã³ãã±ããããã§ã³ããžã¯ããã§ããã¯ããžã¯ããã§ããã¯ãããªãŠã ããã§ã«ããã¯ããããã·ã«ã ãã¹ãããã§ã³ãã€ããããã§ã³ãã€ããããã§ã³ãã³ããŒã«ãã±ããã©ã¯ããªãã«ã€ã³ããã«ã«ããããã§ã³ãã¡ãã§ãã é žãã°ãªãã«ãªãã³é žãžã«ãªãŠã ãåã³ããµã«ãã«é žãšã¹ãã«é¡ãããªã矀ããéžã°ããå°ãªããšãäžã€ã§ããã
åèšèæ¹åæåã¯ããã³ãã§ããŒã«é¡ããã©ã»ã³ã¿ãšãã¹é¡ããã¢ã«ãã³é žé¡ããšã³ã³ã¶ã€ã ãã¢ã«ããã³ãã³ã©ãŒã²ã³é¡ãããªãã§ããŒã«é¡ãã¢ã©ã³ãã€ã³ãã¹ã¯ã¯ã©ã³ããã³ãããŒã«ãã«ããã¬ãšãã¹ãããã¡ãªã¹ãšãã¹ãã©ãã³ããŒãšãã¹ãããã ã®ãšãã¹ããªãªãã¯ãšãã¹ãç±³ãšãã¹é¡ããµã±åµå·£ãšãã¹é¡ããµãã«ããã»ã¹ãç±³çºé µæ¶²ããã¿ãã³ïŒ£é¡ããã¿ãã³ïŒ¥é¡ãåã³ããã¿ãã³é¡ãããªã矀ããéžã°ããå°ãªããšãäžã€ã§ããã
人äœç®èã«å¡åžãä»çãåã¯ã貌ä»ããŠé©çšå¯èœã§ããã
ããšãç¹åŸŽãšããè«æ±é ïŒã«èšèŒã®å«æ°Žçµæç©ã - åèšé²è æ§ä¿é²äœçšãå¥ããåèšå€äŸ¡ã¢ã«ã³ãŒã«ã¯ãå°ãªããšããå šéã«å¯ŸããŠã
ïŒééïŒ ä»¥äžã®ãããã¬ã³ã°ãªã³ãŒã«ã
ïŒééïŒ ä»¥äžã®ããã¬ã³ã°ãªã³ãŒã«ãåã³ã
ïŒééïŒ ä»¥äžã®ã°ãªã»ãªã³ã
ãããªã矀ããéžã°ããå°ãªããšãäžã€ã®å€äŸ¡ã¢ã«ã³ãŒã«ãå«æãã
åèšãã©ãã³é¡ä»¥å€ã®é²è å€ã¯ãå°ãªããšããå šéã«å¯ŸããŠã
ïŒïŒïŒãïŒïŒïŒééïŒ ã®ãã§ããã·ãšã¿ããŒã«ã
ïŒïŒïŒïŒãïŒïŒïŒééïŒ ã®ã«ããªã«é žã°ãªã»ãªã«ãåã³ã
ïŒïŒïŒïŒãïŒïŒïŒééïŒ ã®ããªãªã·ã³ã
ãããªã矀ããéžã°ããå°ãªããšãäžã€ã®ãã©ãã³é¡ä»¥å€ã®é²è å€ãå«æããŠãªãã
ããšãç¹åŸŽãšããè«æ±é ïŒïŒã«èšèŒã®å«æ°Žçµæç©ã - è«æ±é ïŒä¹è³ïŒïŒã®ããããã«èšèŒã®å«æ°Žçµæç©ãå°ãªããšãåãã貌ä»å€ãå粧åããŸãã¯ãå€ç®çšå»è¬åã
- è«æ±é ïŒä¹è³ïŒïŒã®ããããã«èšèŒã®å«æ°Žçµæç©ãšãã·ãŒãç¶ä¿æéšæãšãåãã
åèšå«æ°Žçµæç©ãåèšã·ãŒãç¶ä¿æéšæã«ä»çåã³ïŒåã¯å«æµžããŠä¿æãããŠãªãã
人äœç®èã«è²Œä»å¯èœã«åœ¢æãããé²è æ§ãæããããšãç¹åŸŽãšãã貌ä»å€ã - åèšå«æ°Žçµæç©ã«å«æãããåèšæ©èœæ§æåã¯ãååæ§é çã«ç¶²ç®æ§é ã«æ¶æ©å¯èœãªæ¶æ©æ§æ°Žæº¶æ§é«ååãšååæ§é çã«æ¶æ©ããªãéæ¶æ©æ§æ°Žæº¶æ§é«ååãšãã®ãã¡ã®å°ãªããšãäžã€ã®æ°Žæº¶æ§é«ååãæãã
åèšæ¶æ©æ§æ°Žæº¶æ§é«ååã¯ã
ïŒïœïŒã¢ã¯ãªã«é žãã¡ã¿ã¯ãªã«é žãåã³ããããã®äžäŸ¡ã®éå±å¡©ã®ãã¡ã®å°ãªããšãäžã€ ã®ã¢ã¯ãªã«é žç³»åéäœãéåããŠåŸãããæ¶æ©åã¢ã¯ãªã«é žç³»ããªãã
ïŒïœïœïŒïŒïœïŒã¢ã¯ãªã«é žãã¡ã¿ã¯ãªã«é žãåã³ããããã®äžäŸ¡ã®éå±å¡©ã®ãã¡ã®å°ãªã ãšãäžã€ã®ã¢ã¯ãªã«é žç³»åéäœãšãïŒïœïŒã¢ã¯ãªã«é žã¢ã«ãã«åã³ã¡ã¿ã¯ãªã«é žã¢ ã«ãã«ã®ãã¡ã®å°ãªããšãäžã€ã®ã¢ã¯ãªã«é žã¢ã«ãã«ç³»åéäœãšããå ±éåããŠåŸ ãããæ¶æ©åã¢ã¯ãªã«é žç³»å ±éåããªãã
ïŒïœïœïœïŒããªã¢ã¯ãªã«é žãéšåçã«äžåããéšåäžååããªã¢ã¯ãªã«é žã®æ¶æ©åã¢ã¯ãª ã«é žç³»ããªãã
ïŒïœïœïŒæ¶æ©åã«ã«ããã·ããã«ããªããåã³ïŒåã¯ã
ïŒïœïŒã«ã«ããã·ã¢ã«ãã«ã»ã«ããŒã¹ãããªãŠã ãåã³ïŒåã¯ãããããã·ã¢ã«ãã«ã»ã« ããŒã¹ãããªãŠã ã®æ¶æ©åã»ã«ããŒã¹ååç©ãã§ããã
åèšéæ¶æ©æ§æ°Žæº¶æ§é«ååã¯ã
ïŒïœïœïŒããªããã«ã¢ã«ã³ãŒã«ãããªãšãã¬ã³ã°ãªã³ãŒã«ãããªãããã¬ã³ã°ãªã³ãŒã«ã ã¢ã¯ãªã«é žãã³ãã³ãããªã¢ã¯ãªã«é žã¢ã«ãã«ãããªããã«ãããªãã³ãã«ã«ãã ã·ã¢ã«ãã«ã»ã«ããŒã¹ãããããã·ã¢ã«ãã«ã»ã«ããŒã¹ãã¢ã¯ãªã«é žã¢ã«ãã«ãšå¯ ã¢ãããšã®å ±éåããªãããŒã©ãã³ãåã³ãå¯å€©ããããªã矀ããéžã°ããå°ãªã ãšãäžã€ã®éæ¶æ©æ§æ°Žæº¶æ§é«ååã§ããã
é²è æ§ãæããã
ããšãç¹åŸŽãšããè«æ±é ïŒïŒã«èšèŒã®è²Œä»å€ã - åèšå«æ°Žçµæç©ã«ãããŠã
åèšæ°Žã¯åèšå«æ°Žçµæç©ã®å šå«æéã«å¯ŸããŠïŒïŒãïŒïŒééïŒ ãå«æãã
åèšæ°Žæº¶æ§é«ååã¯åèšå«æ°Žçµæç©ã®å šå«æéã«å¯ŸããŠïŒãïŒïŒééïŒ ãå«æãã
åèšå€äŸ¡ã¢ã«ã³ãŒã«ã¯åèšå«æ°Žçµæç©ã®å šå«æéã«å¯ŸããŠïŒãïŒïŒééïŒ ãå«æããã
ããšãç¹åŸŽãšããè«æ±é ïŒïŒã«èšèŒã®è²Œä»å€ã - è«æ±é ïŒä¹è³ïŒã®ããããã«èšèŒã®é²è æ§ãæããå«æ°Žçµæç©ã®è£œé æ¹æ³ã§ãã£ãŠã
åèšå«æ°Žçµæç©ã¯ã
ïŒïŒ¡ïŒæ°Žãšã
ïŒïŒ¢ïŒåèšæ°Žã«æº¶è§£å¯èœãªæ©èœæ§æåãšã
ïŒïŒ£ïŒåèšæ°Žã«æº¶è§£å¯èœåã¯çžæº¶å¯èœãªé²è æ§ä¿é²äœçšãå¥ããå€äŸ¡ã¢ã«ã³ãŒã«ãšã
ïŒïŒ¥ïŒåèšæ°Žåã³ïŒåã¯å€äŸ¡ã¢ã«ã³ãŒã«ã«æº¶è§£å¯èœãªãã©ãã³é¡ä»¥å€ã®é²è å€ãšã
ãå«æãã
åèšãã©ãã³é¡ä»¥å€ã®é²è å€ãããã§ããã·ãšã¿ããŒã«ãšãã«ããªã«é žã°ãªã»ãªã«ãšãããªãªã·ã³ãšããããªã矀ããéžã°ããå°ãªããšãäžã€ã®ãã©ãã³é¡ä»¥å€ã®é²è å€ã
ãå«æããŠãªãã
ïŒïœïŒå°ãªããšããæ°Žã«å¯æº¶ã§ããæ©èœæ§æåããæ°Žã«æ··å溶解ããããã«ãããæ©èœæ§ æåå«æäºèª¿æ¶²ã調補ããå·¥çšã
ïŒïœïŒãã©ãã³é¡ä»¥å€ã®é²è å€ãšã該é²è å€ã溶解å¯èœãªæ°Žåã³ïŒåã¯å€äŸ¡ã¢ã«ã³ãŒã«ãš ãæ··åããããã«ãããé²è å€ã溶解ãããŠå«æãããé²è å€å«æäºèª¿æ¶²ã調補ã ãå·¥çšã
ïŒïœ ïŒå€äŸ¡ã¢ã«ã³ãŒã«ãšãåèšïŒïœïŒã«ãã調補ãããåèšæ©èœæ§æåå«æäºèª¿æ¶²ãšãå èšïŒïœïŒã«ãã調補ãããåèšé²è å€å«æäºèª¿æ¶²ããæ··åããããã«ãããåèšæ© èœæ§æåãšåèšé²è å€ã溶解ãããŠããå«æ°Žçµæç©ã調補ããå·¥çšã
ãåããããšãç¹åŸŽãšããå«æ°Žçµæç©ã®è£œé æ¹æ³ã - è«æ±é ïŒïŒåã¯ïŒïŒã«èšèŒã®è²Œä»å€ã®è£œé æ¹æ³ã§ãã£ãŠã
åèšå«æ°Žçµæç©ã¯ãïŒïŒ¡ïŒæ°ŽãšãïŒïŒ¢ïŒåèšæ°Žã«æº¶è§£å¯èœãªæ©èœæ§æåãšããŠã®æ°Žæº¶æ§é«ååãšããå«æããããã«ãå°ãªããšãã
ïŒïŒ£ïŒåèšæ°Žã«æº¶è§£å¯èœåã¯çžæº¶å¯èœãªé²è æ§ä¿é²äœçšãå¥ããå€äŸ¡ã¢ã«ã³ãŒã«ãšã
ïŒïŒ¥ïŒåèšæ°Žåã³ïŒåã¯å€äŸ¡ã¢ã«ã³ãŒã«ã«æº¶è§£å¯èœãªãã©ãã³é¡ä»¥å€ã®é²è å€ãšã
ãå«æãã
åèšãã©ãã³é¡ä»¥å€ã®é²è å€ãããã§ããã·ãšã¿ããŒã«ãšãã«ããªã«é žã°ãªã»ãªã«ãšãããªãªã·ã³ãšããããªã矀ããéžã°ããå°ãªããšãäžã€ã®ãã©ãã³é¡ä»¥å€ã®é²è å€ã
ãå«æããŠãªãã
ïŒïœïŒå°ãªããšããæ°Žã«å¯æº¶ã§ãã氎溶æ§é«ååããæ°Žã«æ··å溶解ããããã«ãããç²çš æ§ãæãããšãšãã«æµåæ§ãæãã氎溶æ§é«ååå«æäºèª¿æ¶²ã調補ããå·¥çšã
ïŒïœïŒãã©ãã³é¡ä»¥å€ã®é²è å€ãšã該é²è å€ã溶解å¯èœãªæ°Žåã³ïŒåã¯å€äŸ¡ã¢ã«ã³ãŒã«ãš ãæ··åããããã«ãããé²è å€ã溶解ãããŠå«æãããé²è å€å«æäºèª¿æ¶²ã調補ã ãå·¥çšã
ïŒïœ ïŒå€äŸ¡ã¢ã«ã³ãŒã«ãšãåèšïŒïœïŒã«ãã調補ãããåèšæ°Žæº¶æ§é«ååå«æäºèª¿æ¶²ãšã åèšïŒïœïŒã«ãã調補ãããåèšé²è å€å«æäºèª¿æ¶²ããæ··åããããã«ãããåèš é²è å€ã溶解ãããŠãããšãšãã«ãç²çš æ§ãæãããšãšãã«æµåæ§ãæãããæµå æ§å«æ°Žé«ååçµæç©ã調補ããå·¥çšã
ããã§ã該æµåæ§å«æ°Žé«ååçµæç©ã¯æå®ã®æž©åºŠã«èª¿æŽãããã
ïŒïœïŒåèšïŒïœ ïŒå·¥çšã®åŸã«ã
åèšæµåæ§å«æ°Žé«ååçµæç©ãã²ã«åããè¿ã®æµåæ§ãç¶æããŠããæã«ãåèšã· ãŒãç¶ä¿æéšæã«æå®ã®åãã§åèšæµåæ§å«æ°Žé«ååçµæç©ãä»çåã³ïŒåã¯å«æµž å«äŸµãã
ããã«ãããåèšã·ãŒãç¶ä¿æéšæã«ä¿æãããã·ãŒãç¶ä¿æéšæä»æµåæ§å«æ°Žé« ååçµæç©ã調補ããå·¥çšã
ïŒïœïŒåèšïŒïœïŒå·¥çšã«ãã調補ãããåèšã·ãŒãç¶ä¿æéšæä»æµåæ§å«æ°Žé«ååçµæç© ãæå®æž©åºŠã«èª¿æŽããããã«ãããåèšæµåæ§å«æ°Žé«ååçµæç©ããæµåæ§ãæã ãªãå«æ°Žçµæç©ãåãã貌ä»å€ã調補ããå·¥çšã
ãåããããšãç¹åŸŽãšãã貌ä»å€ã®è£œé æ¹æ³ã
Priority Applications (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2017152771A JP7017680B2 (ja) | 2017-07-20 | 2017-07-20 | å«æ°Žçµæç©ãå«æ°Žçµæç©ãæ§æãã貌ä»å€ãå粧ååã¯å€ç®çšå»è¬åã䞊ã³ã«ããããã®è£œé æ¹æ³ |
JP2021215594A JP7340140B2 (ja) | 2017-07-20 | 2021-12-28 | å«æ°Žçµæç©ãå«æ°Žçµæç©ãæ§æãã貌ä»å€ãå粧ååã¯å€ç®çšå»è¬åã䞊ã³ã«ããããã®è£œé æ¹æ³ |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2017152771A JP7017680B2 (ja) | 2017-07-20 | 2017-07-20 | å«æ°Žçµæç©ãå«æ°Žçµæç©ãæ§æãã貌ä»å€ãå粧ååã¯å€ç®çšå»è¬åã䞊ã³ã«ããããã®è£œé æ¹æ³ |
Related Child Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2021215594A Division JP7340140B2 (ja) | 2017-07-20 | 2021-12-28 | å«æ°Žçµæç©ãå«æ°Žçµæç©ãæ§æãã貌ä»å€ãå粧ååã¯å€ç®çšå»è¬åã䞊ã³ã«ããããã®è£œé æ¹æ³ |
Publications (3)
Publication Number | Publication Date |
---|---|
JP2019019114A JP2019019114A (ja) | 2019-02-07 |
JP2019019114A5 true JP2019019114A5 (ja) | 2020-05-14 |
JP7017680B2 JP7017680B2 (ja) | 2022-02-09 |
Family
ID=65353968
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2017152771A Active JP7017680B2 (ja) | 2017-07-20 | 2017-07-20 | å«æ°Žçµæç©ãå«æ°Žçµæç©ãæ§æãã貌ä»å€ãå粧ååã¯å€ç®çšå»è¬åã䞊ã³ã«ããããã®è£œé æ¹æ³ |
Country Status (1)
Country | Link |
---|---|
JP (1) | JP7017680B2 (ja) |
Family Cites Families (17)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2000239118A (ja) * | 1999-02-18 | 2000-09-05 | Naris Cosmetics Co Ltd | å粧æ |
JP3370289B2 (ja) * | 1999-02-18 | 2003-01-27 | æ ªåŒäŒç€Ÿã¢ã«ãœã¢æ¬ç€Ÿ | å粧æåã³å粧æã®è£œé æ¹æ³ |
JP2004067587A (ja) * | 2002-08-06 | 2004-03-04 | Chisso Corp | å粧æ |
JP2004182639A (ja) * | 2002-12-03 | 2004-07-02 | Shiseido Co Ltd | ç®èå€çšçµæç© |
JP4063775B2 (ja) * | 2003-05-09 | 2008-03-19 | æ ªåŒäŒç€Ÿå£œã±ãã«ã« | ç®èå€çšå€çšæèæ§çµæç©åã³æèæ§ãåããç®èå€çšå€ |
JP2005104929A (ja) * | 2003-10-01 | 2005-04-21 | Kanae Technos:Kk | ããã¯çšã·ãŒããšãã®è£œé æ¹æ³ |
JP4320592B2 (ja) * | 2003-12-24 | 2009-08-26 | ã©ã€ãªã³æ ªåŒäŒç€Ÿ | å»è¬å€çšè²Œä»å€ |
JP4968889B2 (ja) * | 2006-08-22 | 2012-07-04 | æ ªåŒäŒç€Ÿ è³çå | ç®èå€çšçµæç© |
JP2008150311A (ja) * | 2006-12-15 | 2008-07-03 | Lintec Corp | æ°Žæ§ãžã§ã«çµæç©ããã³æ°Žæ§ãžã§ã«è²Œä»å€ |
JP2008247807A (ja) * | 2007-03-30 | 2008-10-16 | Lintec Corp | ã²ã«ããã¯æããã³ã²ã«ããã¯æã®è£œé æ¹æ³ |
WO2010137354A1 (ja) * | 2009-05-27 | 2010-12-02 | 倧æŽéŠææ ªåŒäŒç€Ÿ | é²è å€çµæç© |
JP2013010737A (ja) * | 2011-06-01 | 2013-01-17 | Kose Corp | ãªã³è質å«æçµæç© |
JP5953608B2 (ja) * | 2012-05-25 | 2016-07-20 | æ¥æ¬ãŒããã¯æ ªåŒäŒç€Ÿ | ãã€ãªãã£ã«ã æå¶å€ |
JP6067301B2 (ja) * | 2012-09-28 | 2017-01-25 | æ ªåŒäŒç€Ÿã€ã¯ã«ãæ¬ç€Ÿ | ç®èééé床ã³ã³ãããŒã«å€ |
JP6608310B2 (ja) * | 2015-09-16 | 2019-11-20 | æ ªåŒäŒç€Ÿãã¡ã³ã±ã« | æ°Žäžæ²¹åä¹³åå粧æ |
JP6846109B2 (ja) * | 2016-01-08 | 2021-03-24 | è±çæ ªåŒäŒç€Ÿ | æ°Žç³»ç®èå粧æ |
WO2018181930A1 (ja) * | 2017-03-31 | 2018-10-04 | ç©æ°Žåæåå·¥æ¥æ ªåŒäŒç€Ÿ | ã²ã«ã·ãŒã |
-
2017
- 2017-07-20 JP JP2017152771A patent/JP7017680B2/ja active Active
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN103976886B (zh) | äžç§æ¹æ§èåžãå ¶å¶å€æ¹æ³ååºçš | |
JP5724108B2 (ja) | åçµä¹Ÿç¥çµæç© | |
Grip et al. | Sprayable Carbopol hydrogel with soluble beta-1, 3/1, 6-glucan as an active ingredient for wound healingâdevelopment and in-vivo evaluation | |
JP2010254688A5 (ja) | ||
JP6986581B2 (ja) | ãããå€ | |
CN105267048A (zh) | äžç§æ°åèåžç»ååå ¶åºçš | |
CN113827500A (zh) | ååŠçšåè¶èèåå ¶å¶å€æ¹æ³ | |
WO2016016315A1 (en) | Film-forming complex, cosmetic composition comprising it and their use as peel off film mask | |
JP2016533792A (ja) | ã¹ãã¬ãŒåŒç±å·å 垯 | |
JP2008137970A (ja) | çäœçšç²çã²ã«ã·ãŒãããã³ãããçšããã·ãŒãç¶å粧æ | |
CN103211753B (zh) | äžç§åè¶ååºèŽš | |
US20060079640A1 (en) | Adhesive composition for dermal patch and production process thereof | |
WO2014087419A1 (en) | Oral gel for sensitivity and tooth pain | |
JP2008285461A (ja) | çäœçšç²çã²ã«ã·ãŒãããã³ãããå«ãã·ãŒãç¶å粧æ | |
US9144670B2 (en) | External preparation kit | |
RU2010138947A (ru) | СПÑÑав ÐŽÐ»Ñ ÑПпОÑеÑкПгП пÑОЌеМеМОÑ, ÑПЎеÑжаÑОй ЌОкÑПÑÑеÑÑ Ð°ÐŽÐ°Ð¿Ð°Ð»ÐµÐœÐ° О клОМЎаЌОÑОМ | |
JP6620996B2 (ja) | å«æ°Žé«ååã²ã«è²Œä»å€ãåã³ãå«æ°Žé«ååã²ã«è²Œä»å€ã®è£œé æ¹æ³ | |
KR20110109250A (ko) | ìì±/ë¹ìì± ìœë¬Œì ë¬ì ì ì© ê°ë¥í ê³ ë¶ì íŒí©ë¬Œì ìŽì©í ê³ ë¶ì ìì± íŒí©ì©ì¡ìŒë¡ ë§ë€ìŽì§ íëŠ íì±ì ì¡°ì±ë¬Œ ë° ê·žì ì ì¡°ë°©ë² | |
JP2019019114A5 (ja) | ||
JP2006008615A (ja) | 貌ä»çšã®ãããªãã¯ã¹åã³ãããããªãå粧æ | |
Mishra et al. | Bioadhesive and phase change polymers for drug delivery | |
JP7340140B2 (ja) | å«æ°Žçµæç©ãå«æ°Žçµæç©ãæ§æãã貌ä»å€ãå粧ååã¯å€ç®çšå»è¬åã䞊ã³ã«ããããã®è£œé æ¹æ³ | |
JP2000143547A (ja) | æ°Žæ§ã²ã«åºå€ | |
JP6594937B2 (ja) | ã·ãŒãç¶ããã¯å€åã³ãã®è£œé æ¹æ³ | |
JP2010053130A (ja) | ãããŸãã¯åç©ã®äœãžã®æŽ»æ§æåã®å±æééã®ããã®æ¹è¯ãããçµæç© |